Intel, Oracle, IBM and IonQ join OKX-ICE tokenized stock objections
Image: DecryptIntel, Oracle, IBM and IonQ have joined objections to the OKXICE tokenized stock venue, bringing the total to 26 objecting issuers. OKXICE is a joint venture between Intercontinental Exchange and OKX's U.S. holding company. The platform plans to let approved users trade tokenized U.S. stocks. It is set to operate under the SEC's innovation exemption. The objections concern third-party tokenization of shares.
Key points
- Intel, Oracle, IBM and IonQ joined objections to the OKXICE tokenized stock venue.
- The OKXICE venue now lists 26 objecting issuers.
- OKXICE is a joint venture between Intercontinental Exchange and OKX's U.S. holding company.
- The venue is set to operate under the SEC's innovation exemption.
- Microsoft, Alphabet, Goldman Sachs and Wells Fargo are among the objecting issuers.
Why it matters
The objections affect a planned venue for tokenized U.S. stocks operating under an SEC innovation exemption. The venue would use permissioned liquidity pools for trading.
What's unclear
The exact effect of issuer objections on whether affected shares can trade on OKXICE is unclear, with reports differing on what the objections prevent.
It is uncertain whether tokenized shares in self-custodied wallets would count as customer property or be covered by SIPC if a broker-dealer failed.
Sources · 4 publishers
CoinDesk
Tier 1
Intel, Oracle, IBM join growing list of firms objecting to OKX–ICE tokenized stock plans
Decrypt
Tier 1
Intel, Oracle, IBM Join Objections to OKX-ICE Tokenized Stock Venue, Bringing Total to 26
Bitcoin.com News
Tier 2
Intel, Oracle, IBM and IonQ Join Growing Opposition to OKXICE Tokenized Stock Plan
Coverage timeline
- First reported by Crypto.news
- Also reported by CoinDesk
- CryptoVideos brief published
- 1 more publisher added to sources
- Brief updated
How this page is checked. AI drafted this brief from selected independent reports. Automated checks compare numbers, source coverage and topic terms, but may miss errors. Publication and evidence refreshes run automatically. Read the linked reports for context. Report an error